Overview

Prothena Corporation plc is a biotech company headquartered in Ireland that specializes in discovering and developing novel therapies for neurodegenerative and rare peripheral amyloid diseases. The company's innovative pipeline focuses on protein dysregulation as a key biological pathway for drug development.

Therapeutic areas

Neurodegenerative diseasesRare peripheral amyloid diseases

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to Prothena Corporation plc in our records. PharmaTek screens the full directory against live FDA enforcement data.

Verified Supplier Partner

Is this Prothena Corporation plc? Get in front of buyers actively sourcing.

We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.

No cost to enquire · we only reach out with a fit.

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.